OTC: DSKYF - Daiichi Sankyo Company, Limited

Yield per half year: -33.2%
Dividend yield: +2.00%
Sector: Healthcare

Daiichi Sankyo Company, Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
3/10
46.36 31.48 47.25% 41.96 +10.48%
P/S 5.81 3.24 79.35%
P/BV 5.51 3.36 64.01%
P/FCF 0.1287 21.26 -99.39%
Ev/Ebitda 32.3 9.95 224.45%
Ev/S 5.47 1.89 188.97%
Ev/FCF 18.39 19.96 -7.88%
E/P 3.27 1.47 122.71%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
5/10
16.93 24.35 -30.44% 15.32 +10.54%
ROE 12.81 13.19 -2.89%
ROA 6.72 6.14 9.57%
ROIC 11.02 15.56 -29.19%
ROS 12.53 12.56 -0.2344%
ROCE 7.73 14.36 -46.17%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.375 6.21 -93.96% 0.9449 -60.31%
Nеt Debt/Ebitda -2.01 -5.72 -64.87%
Debt/Ratio 0.0294 0.2122 -86.15%
Debt/Equity 48.9 12.49 291.47%
Debt/Net Income 0.5067 15.05 -96.63%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
5/10
2 1.76 13.54% 1.11 +79.91%
Number of years of dividend growth 1 1.21 -17.44%
DSI 0.9286 0.7783 19.3%
Average dividend growth 16.82 -269.81 -106.23%
Average percentage for 5 years 1.11 2.8 -60.35%
Average percentage for payments 69.84 246.79 -71.7%
Difference from average difference in sector 0.2385

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
8/10
63.14 140.59 -55.09%
Growth impulse Ebitda in 5 years 58.95 107.17 -44.99%
Growth impulse Net Income in 5 years 55.52 123.16 -54.92%
Growth impulse FCF in 5 years 230.8 93.68 146.37%
Growth impulse EPS in 5 years 57.56 229.02 -74.87%
IP Score
6.13/10

Similar companies

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription